4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001513162-17-000258
Options or other derivatives
- Chief Operating Officer acquired 250,000 shares (grant or award)
- Chief Operating Officer returned 250,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Catelani Michael · Chief Operating Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-09-06 | Returned to the company : show line 1 in the form Employee Stock Option | −50,000 | 0 | D |
| 2017-09-06 | Grant or award : show line 2 in the form Employee Stock Option | +50,000 | 50,000 | D |
| 2017-09-06 | Returned to the company : show line 3 in the form Employee Stock Option | −200,000 | 0 | D |
| 2017-09-06 | Grant or award : show line 4 in the form Employee Stock Option | +200,000 | 200,000 | D |
Loading xslF345X03/primary_doc.xml…